• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

Professional Introduction to 3,5-Bis(aminomethyl)benzoic acid (CAS No. 105995-43-5)

3,5-Bis(aminomethyl)benzoic acid, with the chemical formula C?H??NO?, is a versatile compound that has garnered significant attention in the field of pharmaceutical chemistry and biomedicine. This introduction delves into the compound's structural characteristics, synthetic pathways, and its emerging applications, particularly in drug development and molecular biology research.

The molecular structure of 3,5-Bis(aminomethyl)benzoic acid features a benzoic acid core substituted with two amino methyl groups at the 3rd and 5th positions. This unique configuration imparts remarkable reactivity and functional diversity, making it a valuable intermediate in organic synthesis. The presence of both amino and carboxyl functional groups allows for further derivatization, enabling the creation of complex molecules with tailored properties.

In recent years, 3,5-Bis(aminomethyl)benzoic acid has been explored for its potential in medicinal chemistry. Its bifunctional nature makes it an excellent candidate for designing chelating agents, ligands, and probes used in diagnostic imaging. For instance, studies have demonstrated its utility in developing contrast agents for magnetic resonance imaging (MRI), where its ability to coordinate with metal ions enhances signal intensity and specificity.

Moreover, the compound has shown promise in the development of enzyme inhibitors. The amino groups provide hydrogen bonding opportunities with target enzymes, facilitating the design of highly selective inhibitors. Recent research has highlighted its application in inhibiting matrix metalloproteinases (MMPs), which are implicated in various pathological conditions such as cancer metastasis and inflammation. The carboxyl group further allows for pH-sensitive modifications, enabling targeted drug delivery systems.

Another exciting area of application is in the synthesis of peptide mimetics and protease inhibitors. The flexible nature of 3,5-Bis(aminomethyl)benzoic acid allows for the construction of peptidomimetic cores that mimic natural peptide sequences while offering improved stability and bioavailability. This has opened new avenues for treating diseases like neurodegenerative disorders and infectious diseases.

The synthetic routes to 3,5-Bis(aminomethyl)benzoic acid have also seen significant advancements. Traditional methods often involve multi-step reactions with moderate yields and poor regioselectivity. However, recent innovations in catalytic chemistry have enabled more efficient and sustainable synthetic pathways. For example, transition metal-catalyzed cross-coupling reactions have been employed to introduce the amino methyl groups with high precision, reducing byproduct formation and improving overall efficiency.

Biocatalytic approaches have also emerged as a powerful tool for synthesizing 3,5-Bis(aminomethyl)benzoic acid. Enzymes such as transaminases and carboxylases can be engineered to perform specific transformations under mild conditions, aligning with green chemistry principles. These methods not only enhance yield but also minimize environmental impact by reducing waste generation.

The role of computational chemistry in optimizing 3,5-Bis(aminomethyl)benzoic acid derivatives cannot be overstated. Molecular modeling techniques allow researchers to predict binding affinities, optimize drug-like properties such as solubility and metabolic stability, and design novel analogs with enhanced efficacy. This interdisciplinary approach has accelerated the discovery pipeline in drug development significantly.

In conclusion,3,5-Bis(aminomethyl)benzoic acid (CAS No. 105995-43-5) is a multifaceted compound with broad applications in pharmaceuticals and biotechnology. Its unique structural features enable diverse functionalization strategies, making it indispensable in designing innovative therapeutics and diagnostic tools. As research continues to uncover new synthetic methodologies and applications,3,5-Bis(aminomethyl)benzoic acid is poised to play an even greater role in advancing medical science.

• 56-91-7(4-(Aminomethyl)benzoic acid)
• 2393-20-6(3-(Aminomethyl)benzoic acid)
• 96084-38-7(4-(methylamino)methylbenzoic acid)
• 6051-43-0(4-Carbamoylbenzoic acid)
• 4481-28-1(3-Carboxamidobenzoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)